Phibro Animal Health reported $467.16M in Debt for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Ani Pharmaceuticals ANIP:US USD 286.73M 213K
Aurora Cannabis Inc ACB:CN CAD 325.57M 56.08M
Bristol Myers Squibb BMY:US USD 39.1B 2.96B
Canopy Growth Corp WEED:CN CAD 1.48B 111.05M
Depomed DEPO:US USD 68.16M 7M
Eli Lilly And LLY:US USD 15.89B 925.4M
Endo International Ordinary Shares ENDP:US USD 1.42M 8.09B
Henry Schein HSIC:US USD 1.05B 187M
Idexx Laboratories IDXX:US USD 1.39B 14.82M
Knight Therapeutics Inc GUD:CN CAD 39.06M 849K
Lannett LCI:US USD 619.34M 4.39M
Pacira Pharmaceuticals PCRX:US USD 747.87M 7.78M
Patterson Companies PDCO:US USD 662.52M 28.71M
Phibro Animal Health PAHC:US USD 467.16M 34.23M
Prestige Brands PBH:US USD 1.44B 34.77M
Supernus Pharmaceuticals SUPN:US USD 401.44M 529K
Teva Pharmaceutical Industries TEVA:US USD 21.27B 816M
Zoetis ZTS:US USD 6.56B 10M